Gynecologic oncology research, education and awareness took a historic step forward on Jan. 1, 2016, when the Society of Gynecologic Oncology’s Foundation for Gynecology Oncology and the Foundation for Women’s Cancer (FWC) became one foundation...
4-Jan-2016 3:05 PM EST Add to Favorites
Robert L. Coleman, MD, of The University of Texas MD Anderson Cancer Center, Houston, TX, has started his one-year term as the 47th President of the Society of Gynecologic Oncology (SGO) and fifth President of the Foundation for Gynecologic Oncology.
10-Apr-2015 11:05 AM EDT Add to Favorites
Personalized medicine is getting closer to reality for women with late-stage ovarian cancer. An experimental immunotherapy is in the works that can target an individual woman’s tumor and extend the time period between initial treatment and the...
27-Mar-2015 9:00 AM EDT Add to Favorites
Two leading medical organizations say that using a Human papillomavirus (HPV) test alone for cervical cancer screening is an effective alternative to the current recommendation for screening with either cytology (the Pap test) alone or co-testing...
8-Jan-2015 1:00 AM EST Add to Favorites
The Food and Drug Administration’s approval of a nonavalent vaccine against the human papillomavirus (HPV) represents another important step in the eradication of cervical cancer, according to the Society of Gynecologic Oncology (SGO).
10-Dec-2014 4:30 PM EST Add to Favorites
The Society of Gynecologic Oncology (SGO) welcomes new options for detecting and preventing cervical cancer, including the primary human papillomavirus (HPV) testing recently approved by the FDA.
24-Apr-2014 2:00 PM EDT Add to Favorites
Veliparib, an oral cancer drug improves outcomes while minimizing side effects in women with gynecologic cancers who carry a BRCA mutation and whose disease is not responding to other therapies, suggests preliminary research.
21-Mar-2014 9:30 AM EDT Add to Favorites
Women with BRCA1 Mutations May Still Be at Risk for Rare Types of Uterine Cancer After Preventive Surgery to Remove Ovaries, Fallopian Tubes
Women with BRCA1 mutations may have an increased risk for developing rare types of aggressive uterine cancer despite having their ovaries and fallopian tubes removed, suggest preliminary findings.
21-Mar-2014 10:15 AM EDT Add to Favorites
11-Sep-2013 10:00 AM EDT
19-Jun-2013 12:00 PM EDT
14-May-2013 3:45 PM EDT
Cutting HPV Vaccine Costs to Poor Countries Should Spur More Vaccinations in US to Prevent Cervical Cancer
9-May-2013 11:45 AM EDT
SGO Expert Available to Discuss Study About Possible Use of Pap Test to Detect Ovarian and Endometrial (Uterine) Cancers
11-Jan-2013 8:15 AM EST